Therapeutic resistance is one of the characteristics of tumor stemness, so we next explored whether the “RNA–RNA” crosstalk of HMGB1 and RICTOR can influence the therapeutic response of HCC. Here, RICTOR is linked to hepatocellular carcinoma.